S tem cells mediate tissue homeostasis and regeneration, and ageing-associated decline in stem cell compartments contributes to pathophysiology in multiples tissues and organ systems 1,2 . Diminished haematopoietic stem cell (HSC) potential is a driver of ageing in the haematopoietic system [2] [3] [4] . Numerous mechanisms underlie HSC ageing, including the accumulation of DNA damage 5-8 , alterations in the transcriptional programme 9,10 , epigenetic remodelling 11,12 , cell polarity changes 13 , altered lineage output 14 and decreased regenerative potential 9,15-17 . Adult HSCs are largely quiescent, which had been proposed to be a cytoprotective mechanism for preserving genome integrity and long-term function. However, it was recently shown that old HSCs have elevated levels of DNA damage at steady state that are, at least in part, attributable to prolonged periods of dormancy 4 . Upon cell cycle entry, HSCs upregulate the DNA damage response and repair pathways and repair accrued strand breaks 4 .
Results
Aged HSCs show increased survival upon DNA damage induction in vitro and in vivo. As many cancers are treated with genotoxic agents 18 , we investigated how HSCs respond to diverse types of DNA damage and whether this response is differentially regulated during ageing. To address this, single HSCs from young and old mice were sorted via the immunophenotype Linc-kit + Sca-1 + Flk2 -CD34 -/lo ( Supplementary Fig. 2a ), which are CD48regardless of age ( Supplementary Fig. 1a,b ), and exposed to different types of DNAdamaging agents. These included N-ethyl-N-nitrosourea (ENU) and ethyl methanesulfonate (EMS), which induce point mutations, doxorubicin and gamma irradiation (IR), which produce double-strand breaks, and hydroxyurea (HU), which induces replicative stress (Fig. 1a ). In the absence of challenge, young and old HSCs produced similar numbers of colonies when cultured in minimal media (young HSCs: 64.7 ± 14.3% and old HSCs: 62.9 ± 12.4%) ( Fig. 1b) . Strikingly, old HSCs were invariably less sensitive to all genotoxic agents, exhibiting 2-6-fold elevated clonal survival compared to young HSCs depending on the type of DNA damage induced (Fig. 1b,c) . The elevated clonal survival of old HSCs could not be attributed to differences in cell cycle, as both young and old HSCs showed similar cell cycle profiles when freshly isolated and after 18 h of culture ( Supplementary  Fig. 2b) , as well as similar proliferation rates over the first 3 days of culture ( Supplementary Fig. 2c ). Colony size 10-days post-plating was diminished after DNA damage induction irrespective of age, indicating that the total proliferative output of surviving clones was ageing independent ( Supplementary Fig. 2d ,e). The differential survival response to DNA damage induction was specific to old HSCs as single myeloid progenitors (MPs; Linc-kit + Sca-1 -) exposed to EMS, ENU and IR, and multipotent progenitors (MPP1s, Linc-kit + Sca-1 + CD34 + Flk2and MPP2s, Linc-kit + Sca-1 + CD34 + Flk2 + ) exposed to IR gave rise to colonies at similar frequencies ( Fig. 1d-f ) and sizes ( Supplementary Fig. 2f ,g) regardless of age.
Diminished apoptotic priming and ATM signalling confer a survival advantage onto aged haematopoietic stem cells in response to DNA damage
To further investigate the functional impact of DNA damage induction on HSCs, we isolated young and old HSCs, exposed them to either ENU or IR, and then competitively transplanted them into lethally irradiated congenic recipients. As previously reported 9, 15, 17 , old HSCs showed significantly reduced total regenerative potential ( Fig. 2a,b ). However, whereas young HSCs exposed to either ENU or IR showed significantly reduced long-term reconstitution compared to young untreated HSCs, old HSCs exposed to either ENU or IR maintained long-term reconstitution potential comparable to untreated old HSCs ( Fig. 2a,b ). Old HSCs showed myeloid-biased reconstitution as expected, and the lineage potentials of both young and old HSCs were unaltered by DNA damage induction (Fig. 2c,d) . Aged HSCs display elevated survival in response to DNA damage induction. The differential functional response of young and old HSCs observed in vitro ( Fig. 1b ,c) and in vivo ( Fig. 2a ,b) prompted us to explore clonal survival and growth dynamics in response to DNA damage induction. HSCs from young and old mice were clone sorted and were either untreated or exposed to IR, followed by culturing and analysis of viability and cell division daily for 8 days (n = 288 clones per condition) ( Supplementary Fig. 2 ). As we had previously observed ( Fig. 1b ), young HSC clones exposed to IR gave rise to significantly fewer viable colonies than untreated controls, whereas irradiated old HSCs showed no differences in survival compared to untreated old HSCs at any time point ( Fig. 2e -g and Supplementary Fig. 3 ). Strikingly, the greatest loss of viability of young clones occurred within the first 24-h post-IR, prior to the first cell division 4 ( Fig. 2e-g and Supplementary Fig. 1c ), suggesting an intrinsic difference in the ability of young and old HSCs to respond to DNA damage. Consistent with clonal survival and transplantation data, old HSCs exhibited a diminished frequency of apoptotic (annexin V + /propidium iodide (PI + )) cells compared to young HSCs 8-hours post-IR but not at steady-state ( Fig. 2h ,i). This differential apoptotic response was specific to old HSCs as young and old MPs exposed to IR showed similar frequencies of apoptotic cells albeit at higher levels than observed for HSCs ( Fig. 2h ,i).
Aged HSCs exhibit diminished apoptotic priming. Apoptosis is regulated through a balance between pro-apoptotic and anti-apoptotic members of the Bcl-2 family of proteins that controls mitochondrial outer membrane permeabilization (MOMP) upstream of cytochrome c release and caspase activation [19] [20] [21] . This family consists of pro-apoptotic BH3-only proteins, pro-apoptotic effector proteins and anti-apoptotic proteins, which interact to control MOMP. The BH3-only proteins are divided into two groups based on function: the 'activators' (BIM and BID) and the 'sensitizers' (such as BAD, HRK and NOXA) 22 . The activators bind to and inhibit the antiapoptotic proteins, and also directly interact with and activate the effector proteins (BAX and BAK), causing the proteins to promote MOMP 23 . Anti-apoptotic proteins (such as BCL-2, BCL-XL and MCL-1) inhibit apoptosis by binding to BH3-only activators and effector proteins, sequestering them from promoting apoptosis 24 . The BH3-only sensitizer proteins promote apoptosis by binding to the anti-apoptotic proteins, which allows for the release of the activator and effector proteins to initiate MOMP 22,25,26 (Fig. 3a) . Owing Supplementary Table 1 .
to the complex interplay between the numerous proteins involved, combined with their many post-translational modifications that can alter Bcl-2 family protein function 27 , BH3 profiling was developed as a method to evaluate the ability of a cell to undergo apoptosis via the mitochondrial pathway [28] [29] [30] . This technique involves exposing mitochondria of permeabilized cells to peptides derived from the BH3 domains of BH3-only proteins and quantifying MOMP, providing a measure of the readiness of cells to undergo apoptosis (subsequently referred to as apoptotic priming). We previously found that apoptotic priming predicts the clinical response of cancers to cytotoxic chemotherapies 29, 31 and governs healthy tissue sensitivity to ionizing radiation 32 . To determine whether differences in apoptotic priming underlie the differential apoptotic response of young and old HSCs to DNA damage induction, we performed BH3 profiling on HSCs and downstream multi-potent and oligopotent progenitors directly from the marrow of young and old mice ( Supplementary Fig. 4a ). Young HSCs exposed to BIM peptide showed a trend towards diminished apoptotic priming compared to all downstream progenitors that reached significance in comparison to CMP (Linc-kit + Sca-1 -Fcγ Rc
and CLPs (Linc-kit + Sca-1 + Flk2 + IL7Rcα + ) ( Fig. 3b ). This pattern was exacerbated in the bone marrow of old mice with HSCs, which showed significantly diminished priming compared to all downstream progenitors (Fig. 3b ). Comparison of young versus old stem and progenitor cells revealed that HSCs, MPP1s, MPP2s and oligopotent CMPs all showed significantly diminished priming in old mice, with HSCs showing the greatest differential ( Fig. 3b ). This pattern was largely mirrored upon exposure to BID peptide with old HSCs and multi-potent progenitors that were significantly less primed than their young counterparts ( Fig. 3c ). Experiments with HSCs from Bax -/and Bak -/mice showed that HSCs can undergo apoptosis via BAX and/or BAK, as genetic deletion of either apoptosis effector diminished responses to their preferential activators, BIM and BID, respectively 33 , but did not completely eliminate responses ( Supplementary Fig. 4b ,c). Consistent with this, clonal survival upon IR was comparable in HSCs purified from Bax -/or Bak -/mice, indicating functional redundancy of BAX and BAK in HSCs ( Supplementary Fig. 4d ).
To assess the contribution of other Bcl-2 family members to apoptotic priming in young and old HSCs, we interrogated the dependency of HSCs on the anti-apoptotic proteins BCL-2, BCL-XL and MCL-1 using BH3 peptides of the pro-apoptotic sensitizers BAD, HRK and NOXA, which bind to BCL-2/BCL-XL, BCL-XL and MCL-1, respectively ( Fig. 3a ). As we had observed with BIM and BID, old HSCs showed a significantly diminished response to BAD ( Fig. 3d ). Interestingly, murine HSCs exposed to NOXA peptides did not undergo MOMP irrespective of age, indicating that dependency on the anti-apoptotic function of MCL-1 may be less critical in steady-state HSCs than in other contexts [34] [35] [36] . By contrast, MPs were responsive to BAD, HRK and NOXA irrespective of age ( Supplementary Fig. 4e ). Taken together, these data demonstrate that the apoptotic response in steady-state HSCs is BIM-BAX and BID-BAK dependent. Furthermore, these pathways, along with BAD-BCL2, are attenuated in old HSCs.
The primitive HSC compartment is heterogeneous [37] [38] [39] [40] . HSC subsets that bear distinct lineage potentials can be discriminated based on the differential expression of CD150 (CD150 hi , CD150 lo and CD150 neg ) 14, 41 . As expected, the frequency of myeloid-biased HSCs (CD150 hi ) predominated the HSC compartment at the expense of lymphoid-biased CD150 neg HSCs in the bone marrow of old mice, as previously shown 3,14,41 ( Fig. 4a and Supplementary Fig. 4f ). Thus, we explored whether the diminished apoptotic priming observed in old HSCs (Fig. 3b ,c) could be attributable to these HSC subsets. Myeloidbiased CD150 hi HSCs were significantly less primed in response to BIM (old) and BID (young and old) than lymphoid-biased CD150 neg HSCs, whereas lineage-balanced CD150 lo HSCs generally exhibited intermediate responses regardless of age ( Supplementary Fig. 4g ). Comparison between young and old HSC CD150 subsets showed that apoptotic priming was significantly diminished with ageing in Supplementary Table 1 .
response to BIM and BID in all cases, with the exception of CD150 neg in response to BIM (Fig. 4b,c ). Clonal survival in response to IR and ENU revealed that lymphoid-biased CD150 neg HSCs were more sensitive to DNA damage induction, showing reduced survival compared to myeloid-biased CD150 hi HSCs regardless of age ( Fig. 4d ). By contrast, exposure to doxorubicin resulted in significant differences in clonal HSC subset survival ( Fig. 4d ). In all cases, the young HSC subsets were significantly more sensitive to doxorubicin treatment than their old counterparts, and myeloid-biased CD150 hi HSCs were the least sensitive regardless of age ( Fig. 4d ). Competitive transplantation of the HSC subsets from young and old mice showed that IR did not significantly alter the reconstitution potential of these HSC subsets regardless of age, with the exception of lymphoid-biased CD150 neg HSCs purified from young bone marrow ( Fig. 4e-g) . Taken together, these data indicate that the differential response to DNA damage induction displayed by the old HSC compartment (Figs. 1,2) is in part underwritten by differences in apoptotic priming that are both ageing dependent and HSC-subtype dependent.
Transplantation into a young host resets the DNA damage response of aged HSCs. Factors contributing to the decline of HSCs during ageing have largely been linked to cell-autonomous mechanisms 5, 6, 9, [11] [12] [13] [14] [15] [16] [17] 42 . To address whether the ageing-dependent differences in the DNA damage response of HSCs ( Figs. 1-3 ) are cell intrinsic, we transplanted young or old bone marrow cells into young recipients ( Supplementary Fig. 5a ,b) and then assayed apoptotic priming 21-23 weeks post-transplantation in comparison to untransplanted controls. In contrast to the steady state in which old HSCs exhibited diminished apoptotic priming, the priming of old donor-derived HSCs post-transplantation into young recipients in response to BIM, BID and BAD was restored to levels that were comparable to those observed in young HSCs at steady state or post-transplantation ( Fig. 5a ). Apoptotic priming of MPs examined post-transplantation was comparable to steady state and unaltered regardless of donor age ( Supplementary Fig. 5c ). To test whether the normalization of apoptotic priming of old HSCs post-transplantation was concomitant with restoration of the DNA damage response, Supplementary Table 1 .
we assessed the ability of donor-derived HSC clones to form colonies upon IR. In contrast to the differences observed between young and old HSCs examined at steady state (Fig. 1b) , young and old donor-derived HSCs that were isolated post-transplantation into young recipients showed similar clonal survival in response to IR ( Fig. 5b-d) . We next asked whether exposure to an old microenvironment would reciprocally lower the apoptotic priming of young HSCs. We transplanted young bone marrow cells into 17-monthold lethally irradiated recipients ( Supplementary Fig. 5d ,e) and then assayed apoptotic priming 21-23 weeks post-transplantation. Surprisingly, donor-derived young HSCs showed higher levels of apoptotic priming than freshly isolated young HSCs (Fig. 5e ). Interestingly, residual host HSCs of the old recipient also showed significantly higher levels of apoptotic priming than untransplanted controls (Fig. 5e ). Cumulatively, these results demonstrate that the diminished apoptotic priming of old HSCs can be elevated upon transplantation into a young host to levels associated with young HSCs concomitant with a normalization of clonal survival upon exposure to DNA damage, and further suggest that the marrow microenvironment of old mice is altered post-IR, leading to markedly elevated levels of apoptotic priming of both donor-derived and host HSCs. However, at this stage, influences on apoptotic priming by the IR or transplantation procedure cannot be ruled out.
Aged HSCs have diminished ATM activity and DNA damage response. The differential survival of young and old HSCs upon DNA damage induction (Figs. 1,2) combined with the attenuated apoptotic priming (Fig. 3 ) prompted us to ask whether DNA damage signalling might be altered in old HSCs. We first analysed the expression of selected DNA damage response and sensor genes in young and old HSCs; of the 16 genes analysed, 5 (Trp53, Atm, Chk1, Mre11 and Mdc1) were age-regulated genes 43 ( Supplementary  Fig. 6a,b ). Of these, Trp53 was strongly upregulated in old HSCs, whereas all others were downregulated. Of the ageing-downregu- Supplementary Table 1. lated genes, Atm, Mre11 and Mdc1 encode proteins that coordinate DNA damage response, with ATM being the master kinase responsible for signalling double-strand breaks throughout the cell cycle, and MRE11 and MDC1 involved in stabilizing ATM signalling [44] [45] [46] . Atm-deficient HSCs exhibit profound deficiencies in reconstitution potential resulting from the accumulation of reactive oxygen species 47 . Furthermore, ATM phosphorylation of BID has been shown to be critical for HSC survival in response to IR 48 . This led us to test the competency of ATM signalling in response to DNA damage induction in young and old HSCs. Young and old HSCs that were either untreated or exposed to 2 Gy IR were immunostained for γ − H2A histone, member X (γ H2AX) whose phosphorylation is ATM dependent 49 . Consistent with previous reports in mice 5, 50 and in humans 8 , old HSCs showed significantly greater numbers of γ H2AX foci in the untreated samples (Fig. 6a,b) . Strikingly, whereas young HSCs showed greater numbers of γ H2AX foci post-IR, old HSCs showed no change (Fig. 6a,b ) even though double-strand breaks were comparably induced by IR of both young and old HSCs, as shown by quantitation of p53-binding protein 1 (53BP1) IR-induced foci 51 (Fig. 6a,c) and comet assays ( Supplementary Fig.  6c ,f). The deficit in ATM signalling in old HSCs was also observed in vivo, as HSCs purified from old irradiated mice failed to induce γ H2AX foci (Fig. 6d,e ). These data indicate that ATM signalling in response to acute DNA damage induction is compromised in old HSCs. However, this deficit in ATM signalling did not affect the ability of old HSCs to repair double-strand breaks, as young and old HSCs exhibited similar kinetics of repair as indicated by timecourse resolution of comet tails and 53BP1 foci post-IR ( Fig. 6f,g) .
To explore whether the reduced ATM activity of old HSCs could be linked to diminished apoptotic priming, we analysed apoptotic priming in LSKs (Linc-kit + Sca-1 + ) and MPs from young and old mice in response to IR in the presence or absence of the ATM inhibitor KU-55933 (ref. 52 ) at a dose that inhibited ATMdependent γ H2AX activity in LSK-enriched and c-kit-enriched cells ( Supplementary Fig. 6d,e ). ATM inhibition was sufficient to significantly reduce apoptotic priming in both young and old LSKs and MPs upon exposure to IR (Fig. 6h) and to increase the survival of young irradiated HSCs (Fig. 6i) . These results suggest that ATM has a role in regulating apoptotic priming in haematopoietic progenitor cells, and raise the possibility that the diminished apoptotic priming associated with HSC ageing may be underwritten by diminished ATM signalling. As apoptotic priming was elevated upon transplantation of old HSCs into young irradiated recipients ( Fig. 4a,b) , we tested whether ATM signalling (Fig. 6a-c) was concomitantly restored post-transplantation into young hosts. To address this, we analysed the bone marrow of mice that had been transplanted 21-23 weeks previously with young or old whole bone marrow ( Supplementary Fig. 4a ). Strikingly, untreated young and old HSCs analysed post-transplantation showed comparable basal levels of γ H2AX and 53BP1 (Fig. 6j,k) and a comparable ability to induce γ H2AX and 53BP1 foci upon IR irrespective of donor age (Fig. 6j,k) , indicating that ATM activity had been restored in old HSCs upon transplantation into a young host.
Discussion
In this study, we show that old HSCs are more resistant to DNAdamage-induced apoptosis than young HSCs regardless of the type of DNA lesion induced. This generalized response points towards a common mechanism underlying the survival advantage of old HSCs rather than differential activity of specific DNA repair pathways. Indeed, using BH3 profiling, we show that, during ageing, HSCs become less primed for apoptosis underwritten by diminution of BIM-BAX, BID-BAK and BAD-BCL-2 responses. We discovered that the survival advantage of old HSCs in response to DNA damage induction could be reset to a level comparable with young HSCs upon transplantation into young hosts, which suggests an important role for the microenvironment in regulating apoptotic priming. In addition, we uncovered a role for ATM in regulating apoptotic priming and survival in haematopoietic progenitors and showed that old HSCs have diminished ATM activity in response to acute DNA damage induction. Whether ageing-associated cellular alterations in the niche, differences in downstream blood progenitors/ effectors or humoral signals emanating from the microenvironment underlie the differential regulation of apoptosis of HSCs during ageing impinge directly on ATM activity or represent independent mechanisms is still unclear. Nonetheless, the fact that transplantation into a young host restored ATM activity in old HSCs concomitant with normalization of apoptotic priming and survival of HSCs in response to DNA damage induction suggests that the aged niche may have a critical role in regulating ATM activity and the DNA damage response during HSC ageing. Taken together, these results suggest that the diminished apoptotic priming observed in old HSCs could underlie the perpetuation of the stem cell pool even in the face of DNA damage by providing a selective advantage to old HSCs that are rendered insensitive to DNA lesions that would otherwise kill their younger counterparts. Consistent with this idea, p53 has been shown to act as a critical mediator of cell competition in stem and progenitor cells with levels of DNA damage that do not reach a threshold high enough to activate apoptosis, allowing damaged stem cells to survive and propogate 53 . In a comparable manner, diminution of apoptotic priming provides a mechanism that allows damaged HSCs, particularly myeloid-biased HSCs, to survive and propagate in the aged marrow, thereby contributing to the oligoclonal expansion of the HSC compartment observed in mice and hum ans 14, 37, 39, 54 . Such a selective advantage may also underlie the accrual of DNA damage in the HSC compartment 4,55-59 , ultimately leading to ageing-associated haematopoietic malignancies.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41556-018-0054-y.
Results presented in this study are drawn from each and every experiment that did not fail for technical reasons, and only experiments that failed for technical reasons were excluded. No other exclusion criteria were applied.
Mice. All mice used were C57BL/6 males. Young mice were 12-14-weeks old. Old mice were obtained from the National Institute on Aging and were 24-26-months old. All mice were maintained according to protocols approved by Harvard Medical School Animal Facility Administrative Panel on Laboratory Animal Care, and all procedures were performed with consent from the local ethics committees (Institutional Animal Care and Use Committee (IACUC) Harvard Protocol 04428).
Purification of cells.
Adult bone marrow cells were extracted by crushing the bones of donor mice. Cells were enriched using c-kit magnetic beads (Miltenyi) and stained with the following cell surface antibodies for 1.5 h on ice: Lin cocktail (Mac1, Gr1, Ter119, B220, CD3, CD4 and CD8), c-kit, Sca-1, CD34, Flk2, Fcγ R, IL7Ra, CD150, CD45.1 and CD45.2. All cells were sorted on a FACSAria II (Becton Dickinson), and PI was used to exclude dead cells.
Cell culture. Cells were clone sorted into 96-well round-bottom plates. HSCs were cultured in S-Clone (Iwai North America Inc.) supplemented with 0.75% AlbuMAX-I (Gibco), 1× penicillin/streptomycin, 50 mM 2-mercaptoethanol (Invitrogen) and the following cytokines: 20 ng per ml mouse stem cell factor, 20 ng per ml mouse thrombopoietin, 20 ng per ml mouse IL-12. MPs and c-kitenriched cells were cultured in Dulbecco's modified Eagle's medium and F-12 medium (Gibco and Invitrogen) supplemented with 10% fetal calf serum (Hyclone and Thermo Scientific), 1× penicillin/streptomycin, 2 mM GlutaMAX, 50 mM 2-mercaptoethanol and the following cytokines: 20 ng per ml mouse stem cell factor, 20 ng per ml mouse thrombopoietin, 20 ng per ml mouse IL-3 and 20 ng per ml mouse granulocyte-macrophage colony-stimulating factor (all purchased from PeproTech). c-kit-enriched bone marrow (2 × 10 6 cells per ml) was exposed for 4 h to 10 μ M ATM inhibitor (KU55933, Selleckchem). All cells were kept in a 5% O 2 incubator.
Survival assays. For each experiment, 24-48 individual cells from individual mice were analysed. Cells were either irradiated with 2 Gy or treated for 18 h with 0.2 mg per ml ENU, 0.2 mg per ml ethyl-methanesulfonate, 0.5 mM HU or 250 ng per ml doxorubicin (all from Sigma). For HSC survival upon ATM inhibition, single cells were pre-treated with 10 μ M ATM inhibitor (KU55933, Selleckchem) for 4 h and irradiated with 2 Gy. After the incubation time, media were refreshed with drugfree media. Cells were incubated at 37 °C in a humidified atmosphere with 5% CO 2 . At 8 days of culture, colonies were counted under the microscope. At 10 days of culture, the size of each colony was measured under a microscope. For the cell growth dynamics assay, either freshly isolated young and old or donor-derived young and old HSCs were counted under the microscope every 24 h for 8 days. Viability was determined by appearance.
Annexin V assays. HSCs and MPs were isolated and either stained immediately after purification or irradiated and kept in culture for 8 h. Cells were stained following the manufacturer's protocol (annexin V Apoptosis Detection kit, BD Pharmingen).
Transplantation. For competitive transplantation upon DNA damage induction, 500 CD45.2 HSCs or CD150 hi , CD150 lo or CD150 neg HSCs were transplanted into lethally irradiated (10 Gy) CD45.1 8-12-week-old female recipients along with 3 × 10 5 competitor congenic bone marrow cells. For non-competitive transplantation, 5 million whole bone marrow cells were transplanted into lethally irradiated (10 Gy) CD45.1 8-12-week-old female recipients or 17-month-old CD45.2 males. Peripheral blood analysis was performed at 4-week intervals posttransplantation using antibodies against Ter119, B220, Mac1, Gr1, CD3, CD45.1 and CD45.2. PI was used to exclude dead cells. BH3 profiling. Bone marrow cells from young and old mice or from transplanted mice were isolated, c-kit enriched using separation columns (Miltneyi) and stained with antibodies to identify bone marrow populations as described above. For BH3 profiling, cells were resuspended at 2 × 10 6 cells per ml and incubated with 20 μ g per ml oligomycin, 0.0005% digitonin and BH3 peptides at indicated concentrations (for amino acid peptide sequences for BH3 peptides, see ref. 60 ) in DTEB buffer (135 mM Trehalose, 10 mM HEPES-KOH, 0.1% w/v BSA, 20 μ M EDTA, 20 μ M EGTA, 50 mM KCl and 5 mM succinate, final pH 7.4) for 30 min (BIM and BID) or 60 min (BAD, HRK and NOXA). 15 min prior to the completion of the peptide incubation, tetramethylrhodamine (TMRE) was added to a final concentration of 20 nM. Cells were analysed by flow cytometry to assess mitochondrial depolarization on the BD Canto II Analyzer. Peptide and TMRE incubation was performed on heating blocks at 22 °C. The percentage of depolarization was calculated from the median fluorescence intensity (MFI)) of the TMRE peak as: Immunostaining. HSCs were sorted, irradiated and kept in culture for 1 h in S-Clone media and then fixed with 4% paraformaldehyde for 30 min at room temperature. Cells were permeabilized (0.1% Triton, 2% goat serum in PBS) for 15 min at room temperature, blocked (2% goat serum with 0.03% Tween in PBS) for 1 h at room temperature and incubated with the primary antibodies anti-γ H2AX (BioLegend) and anti-53BP1 (Novus Biologicals) at 1:1,000 dilution for 36 h at 4 °C. Then, HSCs were incubated with the secondary antibodies antirabbit Alexa Flour 594 (A21207) and anti-mouse Alexa Flour 488 (A10667) for 1 h at room temperature. To visualize the nuclei, the cells were counterstained by 4,6-diamidino-2-phenylindole (DAPI). To remove the permeabilization solution, primary and secondary antibodies, respectively, the cells were washed several times in 0.03% Tween in PBS. Finally, the cells were transferred to slides and mounted on Vecta-Mount. Images were acquired on a Carl Zeiss Observer Z.1 fluourescent microscope and processed by ImageJ 1.49 v. Several hundreds of HSCs from four (53BP1) and six (γ H2AX) experiments were scored blindly. Foci were counted manually, and statistics were done using GraphPad Prism. Dot blot. LSKs were sorted, irradiated and cultured in F12 complete media for 1 h. Then, cells were lysed in modified Laemmli buffer (240 mM Tris/HCl pH 6.8, 8% SDS and 5% β -mercaptoethanol) at 5 × 10 5 cells per ml and incubated for 10 min at 99 °C. 30 × 10 5 LKSs were spotted on a 0.2-μ m nitrocellulose membrane (BioRad), dried, washed with PBST (0.1% Tween 20 in PBS) and blocked overnight at 4 °C in 5% BSA in PBST. Primary antibodies (anti-H2A.X Phospho-Ser139 (BioLegend) and actin (Santa Cruz)) were used at 1:1,000 for 2 h at room temperature in 0.5% BSA in PBST. Secondary antibodies (anti-mouse HRP (Santa Cruz) and anti-goat HRP (Jackson)) were incubated at 1:2,000 in 0.5% BSA in PBST. Membranes were washed 3 times for 15 min in PBST. Dot blot was developed using SuperSignal West Femto (ThermoFisher Scientific) and Amersham Hyperfilm ECL (GE Healthcare).
Comet assay. Young and old HSCs were sorted, irradiated (2 Gy) and cultured in S-Clone for 1 h. Then, alkaline comet assays were done as described previously 4 .
Statistics and reproducibility.
Statistical analysis (two-tailed Student's t-test and log-rank test) was performed using GraphPad Prism. Experiments were repeated at least three times, except for those in Figs. 2a,c, 3d, 5e and Supplementary Figs. 2d-g and 3e, which were repeated twice and Figs. 2b,d, 4e-g, 6d-g,i and Supplementary Figs. 5a,b,d ,e, and 6c,e, which were performed once. Experiments that were only performed once or twice include multiple biological replicates (survival, transplants and BH3 profiling after ATM inhibition) or are assays in which different experiments should not be pooled and compared (comet assay). When data were pooled from different experiments, all replicates were done in the same conditions. Life Sciences Reporting Summary. Further information on experimental design is available in the Life Sciences Reporting Summary.
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